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In the arms race of host–microbe co-evolution, macrophages (Mφs) have been endowed
with strategies to neutralize pathogenic challenge while preserving host integrity. Dur-
ing steady-states conditions, Mφs perform multiple house-keeping functions governed by
their differentiation state, tissue distribution, and signals from the microenvironment. In
response to pathogenic challenge and host mediators, however, Mφs undergo different
programs of activation rendering them either pro-inﬂammatory and microbicidal (M1), or
immunosuppressants and tissue repairers (M2). An excessive or prolonged polarization of
either program may be detrimental to the host due to potential tissue injury or contribution
to pathogenesis. Conversely, intracellular microbes that cause chronic diseases such as
tuberculosis and acquired immunodeﬁciency syndrome exemplify strategies for survival in
the host. Indeed, both Mycobacterium tuberculosis (Mtb) and human immunodeﬁciency
virus (HIV-1) are successful intracellular microbes that thrive in Mφs. Given these microbes
not only co-circulate throughout the developing world but each has contributed to preva-
lence and mortality caused by the other, substantial insights into microbe physiology and
host defenses then rest in the attempt to fully understand their inﬂuence on Mφ polariza-
tion. This review addresses the role of Mφ polarization in the immune response to, and
pathogenesis of, Mtb and HIV.
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INTRODUCTION
Pathogens have evolved ingenious strategies to circumvent the host
immune response as part of the constant evolutionary process-
taking place in all living organisms. Chief among these strategies
is the prevention of the inﬂammatory response or seizure of the
anti-inﬂammatory mechanism in place to protect tissue integrity.
The manipulation of macrophage (Mφ) polarization is one of the
main targets to accomplish this, since this antigen presenting cell
represents the ﬁrst line of an active defense system in the host,
and if successfully done, it can then undermine adaptive immu-
nity (Benoit et al., 2008). Mφ polarization is a dynamic process
governed by mechanisms dictating their tissue distribution and
functional capacities in response to endogenous and exogenous
signals (Martinez et al., 2009). Polarized Mφs are broadly classi-
ﬁed into two groups: classical (M1) and alternative (M2) activated.
On one hand, M1 program is a direct response to type-1 inﬂam-
matory conditions (e.g., IFN-γ) and pathogen challenge, and it
has been associated to resistance to intracellular pathogens and
to some form of tumors. On the other hand, the M2 program
is driven by type-2 inﬂammatory signals such as IL-4 and IL-13
(M2a); immune complexes, toll-like receptors (TLRs) agonists, or
IL-1 receptors (M2b); and immunosuppressants including IL-10,
transforming growth factor-β (TGF-β) or glucocorticoids (M2c;
Table 1). M2 Mφs participate in diverse activities including the
suppression of inﬂammation, enhancement of phagocytosis, pro-
motion of tissue remodeling and repair, elimination of parasites,
andunwanted tumor angiogenesis (Sica et al., 2008;Martinez et al.,
2009; Murray and Wynn, 2011). Furthermore, it is becoming clear
thatMφ polarization supports different, and in some cases, oppos-
ing biological functions, that inﬂuences tissue homeostasis, and
numerous pathological situations, including infectious diseases
(Benoit et al., 2008; Cairo et al., 2011). Given the pivotal role Mφs
play as sentinels of the immune system, they represent ideal cell
targets for subversion by successful intracellular pathogens.
The purpose of this short review is not to provide a com-
prehensive summary of Mφ polarization; others have recently
reviewed this growing research area (Martinez et al., 2009; Murray
and Wynn, 2011). Also, we will not address the multiple ways by
which the pathogens in question circumvent the immune system,
as there are excellent reviews covering this subject (Deretic et al.,
2004; Carter and Ehrlich, 2008; Meena and Rajni, 2010; Hajishen-
gallis and Lambris, 2011). Instead, we will focus exclusively on
the signiﬁcance of Mφ polarization in the context of pathophys-
iology caused by Mycobacterium tuberculosis (Mtb) and human
immunodeﬁciency virus (HIV).
MACROPHAGE POLARIZATION IN Mtb INFECTION
Theworld health organization reports tuberculosis (TB) is still one
of the leading causes of death due to a single infectious agent (Mtb)
with 1.7 million deaths and 9.4 million new cases in 2009, and
estimates that about one-third of the human population may be
latently infected (WHO Global Tuberculosis Control Report 2010,
2010). Active TB may occur directly after infection or through the
reactivation of latent infection that is conﬁned in granulomas. The
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Table 1 | Priming stimulus for the classical (M1) and alternative
(M2a-c) activation of macrophages.
M1 program M2 program
M2a M2b M2c
Priming
stimulus
IFN-γ+ LPS
or TNF
IL-4 Immune
complexes
IL-10
IL-13 TLR ligands TGF-β
IL-1R ligands Glucocorticoids
MCSF
elaboration and maintenance of granulomas depends on a dedi-
cated immune response, which is not fully understood. Recently,
however, it was demonstrated mycobacteria exploits Mφ activa-
tion to turn the granuloma into an effective tool for pathogenesis
(Davis and Ramakrishnan, 2009;Volkman et al., 2010). Therefore,
a better understanding of Mφ polarization during Mtb infection
might yield further clues about how Mtb circumvents the immune
system.
As aforementioned,Mφ polarization is mainly driven by type-1
and type-2 inﬂammatory signals (Table 1). Type-1 inﬂamma-
tory cytokines are essential in the defense against Mtb since
their expression often correlates with efﬁcient anti-Mtb immune
responses, and genetic deﬁciencies of these factors lead to increased
TB susceptibility (Quintana-Murci et al., 2007). IFN-γ drives the
M1program characterized byMφ capacity to killmostmycobacte-
ria and restrict the replication of the remainder (Ehrt et al., 2001).
The early phase of the anti-Mtb immune response is marked by
M1Mφpolarization inmultiple animalmodels and reminiscent of
the clinical data collected from patients with active TB (Figure 1;
Benoit et al., 2008). At the transcriptome level, the gene modula-
tion inducedbyMtb inMφs highly overlaps,and in somecases syn-
ergizes, with that induced by IFN-γ to establish the M1 phenotype
(Ehrt et al., 2001). At the granuloma level in mice, M1 Mφ polar-
ization is evident inmice between 7 and 30 days afterMtb infection
when high levels of IFN-γ and iNOS are also detected within this
structure and around the alveolar compartment (Redente et al.,
2010). All in all, polarization of M1 Mφs is part of the “com-
mon host response” against intracellular bacteria characterized
by high expression of iNOS and consequent nitric oxide (NO)
production (characteristic of murine models), secretion of pro-
inﬂammatory cytokines and chemokines, release of proteolytic
enzymes and anti-microbial peptides, enhanced phagocytosis, and
development of a toxic intracellular environment reﬂected in the
fusion of microbial phagosomes with acidic and hydrolase-rich
lysosomes (Ehrt et al., 2001; Deretic et al., 2004; Martinez et al.,
2009; Cairo et al., 2011; Murray and Wynn, 2011). It remains to be
demonstrated whether transcription factors [e.g., p65 and inter-
feron regulatory factor (IRF5)] or regulators (e.g., SHIP1) that
dictate the M1 program of macrophage polarization also play a
role in TB infection (Martinez, 2011). Considering this hostile
environment created by M1 Mφs, it is not surprising Mtb has
evolved strategies to interfere with M1 polarization. Indeed, Mtb
inhibits IFN-γ activation of Mφs by secreting virulence factors
such as lipoarabinomannan that halters phagosome maturation,
or early secretory antigenic target-6 (ESAT-6) that prevents the
activation of NF-κB and IFN-γ regulatory factors downstream
of TLR-2 (Deretic et al., 2004; Benoit et al., 2008). Indirectly, Mtb
blocks M1 polarization by the transcriptional inhibition of IFN-γ-
responsive genes through a bystander effect involving IL-6 (Sibley
et al., 1990; Benoit et al., 2008).
Perhaps the best strategy to avoid the challenges posed by M1
Mφs is to shift their program into M2 Mφs. TB susceptibility
parallels with elevated levels of type-2 inﬂammatory signals (e.g.,
IL-4, IL-13; Kahnert et al., 2006; Raju et al., 2008; Almeida et al.,
2009; Schreiber et al., 2009). Likewise, high levels of IL-10 (mostly
derived from Mφs) correlate with active TB patients (Barnes et al.,
1993; Verbon et al., 1999). Interestingly, the predominant type-2
inﬂammatory environment shifts back to type-1 after successful
treatment of pulmonary TB in infected patients (Verbon et al.,
1999; Raju et al., 2008). These observations in humans parallel
with those reported in Mtb-infected mice; that is, there is an early
type-1 immune response characterized by IFN-γ during the ﬁrst
3 weeks after infection, followed by a type-2 immune response that
contains high levels of IL-4 (Figure 1; Orme et al., 1993). A type-2
inﬂammatory environment drives the M2 program that renders
Mφs immunomodulatory and poorly microbicidal (Raju et al.,
2008; Martinez et al., 2009). At the transcriptome level, this seems
to be the case inmice sinceM2Mφs displayed adiminished inﬂam-
matory response to Mtb as reﬂected by a reduced NO production
and increased of iron availability, suggesting these phagocytes offer
a permissible intracellular environment for bacterial replication
(Kahnert et al., 2006). Indeed, IFN-γ-induced NO production is
essential for host survival with respect of experimental TB, while
iron-starvation is key to bacteriostasis (Ehrt et al., 2001; Forbes
and Gros, 2001; Cairo et al., 2011). It remains to be seen if Mtb
also inﬂuences the expression level of Kruppel-like factor 4 (KLF4)
or any other transcription factor/regulator recently shown to be
critical for both the establishment of the M2 program and the
inhibition of M1 polarization (e.g., STAT6, Cot/tpl2; Liao et al.,
2011; Martinez, 2011). At the functional level, it has been demon-
strated that both IL-4 and IL-13 inhibit autophagy in M1 Mφs
resulting in enhanced survival of Mtb, an impairment that might
also extend to M2a Mφs (Harris et al., 2007). At the granuloma
level in mice, iNOS continues to be expressed within this struc-
ture but a signiﬁcant shift from M1 toward M2 Mφs [iNOSneg
Arginase-1 (ARG1)hi] occurs around the alveolar compartment
starting at day 35 and continuing up to day 60 after Mtb infec-
tion, accompanied by high levels of type-2 inﬂammatory signals
(Ly et al., 2007; Redente et al., 2010). Given the development of
ﬁbrosis is a key characteristic of caseous granulomas during Mtb
dissemination, and that M2 Mφs have been implicated in the inhi-
bition of ﬁbrosis development, the shift fromM1 intoM2program
might represent an attempt by the host to halter the pathophysiol-
ogy caused by Mtb or a microbial strategy to shield from immune
attack (Dorhoi et al., 2011).
Mycobacterium tuberculosis also reprograms M2 Mφs through
secretion of immunosuppressants such as IL-10. For instance,
Mtb might inﬂuence all TLR-dependent signaling by targeting
DC-SIGN to induce IL-10 and counteract the pro-inﬂammatory
response, as shown in dendritic cells (Geijtenbeek et al., 2003;
Hajishengallis and Lambris, 2011). Likewise, the mannosylated
Frontiers in Immunology | Inﬂammation September 2011 | Volume 2 | Article 43 | 2
Lugo-Villarino et al. Macrophage polarization in tuberculosis and AIDS
FIGURE 1 | A model illustrating the putative involvement of macrophage polarization during Mtb or HIV-1 infection.
lipoarabinomannan from Mtb enhances the production of IL-10
and other immunosuppressants through recognition by the man-
nose receptor (MR) in immature dendritic cells (Chieppa et al.,
2003). Although alveolar Mφs express DC-SIGN and MR, their
role in M2 Mφs has yet to be demonstrated (Chroneos and Shep-
herd, 1995; Tailleux et al., 2005). Nevertheless, Schreiber et al.
(2009) reported Mtb-induced IL-10 in Mφs promotes the M2
polarization program displaying diminished anti-mycobacterial
effector mechanisms. Indeed, Mφ-speciﬁc overexpressing IL-10
transgenic mice were indeed susceptible to Mtb infection, dis-
played a speciﬁcally suppressed IL-12 in infected tissues, and were
characterized by lung Mφs with a M2 phenotype permissive to
Mtb infection (Schreiber et al., 2009). These observations cor-
relate well with another study in mice where Mtb was shown to
promote its survival and ability to cause disease through aMyD88-
dependent induction of ARG1. ARG1 inhibits NO production by
Mφs by competing with iNOS for arginine (the common sub-
strate), thus rendering these cells permissive to Mtb infection
(El Kasmi et al., 2008; Hajishengallis and Lambris, 2011). Taken
together, these observations suggest the reprogramming toward
M2 Mφs by IL-10, and other immunosuppressants such TGF-β
and glucocorticoids (Hernandez-Pando et al., 2006), might be yet
another adaptation by Mtb to survive and thrive inside of Mφs
(Figure 1). However, it should be noticed that this phenomenon
might also represent a control mechanism by the host to preserve
the integrity of mucosal sites as uncontrolled type-1 inﬂamma-
tory responses against Mtb result into lung immunopathology
(Hernandez-Pando et al., 2006; Ordway et al., 2006).
MACROPHAGE POLARIZATION IN HIV INFECTION
Human immunodeﬁciency virus-1 is another successful intracel-
lular pathogen responsible for a worldwide pandemic. According
to 2009 estimates by theUnitedNations, therewere about 33.2mil-
lion people worldwide living with HIV-1 infection and 2.6 million
individuals had been newly infected (Cohen et al., 2011). In the
absence of antiviral therapy, HIV-1 infection progresses through
acute and asymptomatic stages leading to the eventual failure
of the host immunological functions and acquired immunodeﬁ-
ciency syndrome (AIDS). A reason is that HIV-1 targets cells from
the mononuclear phagocyte lineage that drive an effective antivi-
ral response and simultaneously serve as reservoirs of latent or
productive infection (Goodenow et al., 2003). Among these cells,
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Mφs are critical to pathogenesis because they contribute to early
transmission, systemic dissemination, and persistence of HIV-1.
Indeed,HIV-1 evades immune surveillance by hiding and thriving
inside Mφs despite anti-retroviral treatment, and when infected,
they persist for months displaying insensitivity to viral cytopathic
effects. In addition, Mφs continuously secrete high level of viral
particles over prolonged time periods by storing assembled virus
in specialized endosomal compartments (Orenstein et al., 1988;
Benaroch et al., 2010). Thus, they represent powerful long-term
viral reservoirs (Goodenow et al., 2003; Carter and Ehrlich, 2008;
Herbein and Varin, 2010; Cohen et al., 2011). In light of recent
evidence suggesting that M1 and M2 Mφs inﬂuence HIV-1 patho-
genesis, there is a surging interest to study the viral effects in Mφ
polarization.
In vitro,HIV-1 infectiondrivesMφs toward aM1program.This
Mφ response includes production of type-1 pro-inﬂammatory
cytokines (IFN-γ, IL-2, IL-12, TNFα, IL-1β, IL-6, IL-18) and
chemokines (CCL3, CCL4, MIP-α, MIP-β, RANTES), increased
NO and respiratory burst, up-regulation of MHC-II molecules,
and down-regulation of HIV-entry receptors (e.g., CD4, CCR5,
CXCR4), and endocytic receptors (e.g., CD163, CD206; Swingler
et al., 1999; Cassol et al., 2009, 2010; Herbein and Varin, 2010).
Although few studies have examined thoroughly HIV-induced
polarization of Mφs in vivo, there is a predominance of Mφs dis-
playing a M1 phenotype during the acute stage (Figure 1; Cassol
et al., 2010; Herbein andVarin, 2010; Cohen et al., 2011). Whether
M1 Mφs are beneﬁcial to the host during HIV-1 infection remains
an open question since Mφ functions vary according to the exper-
imental context. For instance, in vitro infection of M1 Mφs in the
presence of IFN-γ and TNFα is associated with a suppression of
HIV-1 replication, a sharp decrease in HIV-1 DNA synthesis at
48 h, and a decrease in the accumulation of HIV-1 proteins (Cas-
sol et al., 2009). In addition, other studies demonstrate that M1
Mφs inhibit viral entry, assembly, and budding, suggesting the M1
program can be beneﬁcial to the host (Cassol et al., 2010; Herbein
andVarin, 2010). However, it is also known that pro-inﬂammatory
signals deriving from M1 Mφs favor the formation of viral reser-
voirs with increased transcription of HIV-1 LTR (long terminal
repeat), alluding M1 Mφs might beneﬁt HIV pathogenesis (Cassol
et al., 2010; Herbein and Varin, 2010). This is supported by multi-
ple observations that immune activation driven by Mφs correlates
with HIV-1 pathogenesis (Goodenow et al., 2003; Lamers et al.,
2009; Cohen et al., 2011). Recently, Brown et al. (2008) charac-
terized the HIV-1-induced polarization of Mφs as “M1HIV” since
it displays a pro-inﬂammatory state with increased production
of cytokines independently of TLR-pathway. The authors argue
that while HIV-1 stimulates Mφs through a variety of signaling
pathways to promote a “tailored” inﬂammation in its favor, the
TLR recognition of viral replication is impaired and could serve as
a viral evasion strategy. Given that prolonged pro-inﬂammatory
Mφ activation during chronic HIV-infection contributes, not only
to a permissive environment for the formation of viral reservoirs
with strong transcriptional activity, but also to disease progression
and HIV-induced tissue damage, the proposed M1HIV polarized
state may render Mφs detrimental to the host (Goodenow et al.,
2003; Brown et al., 2008; Lamers et al., 2009).
As HIV-disease progresses from the acute to asymptomatic
stage, there is a switch from a type-1 toward a type-2 inﬂamma-
tory environment (Figure 1; Vasilescu et al., 2003; Becker, 2004).
At the transcriptional level, lymphatic tissue microarray analyses
from HIV-1-infected subjects at different clinical stages revealed
that each stage has a unique gene proﬁle (Li et al., 2009). The
acute phase is characterized by gene expression involved in innate
and adaptive immunity. The asymptotic phase, however, down-
regulates the acute phase gene proﬁle to baseline level while it
displays an increased expression of immunosuppressive genes (Li
et al., 2009). Based on these immunological systemic changes, it
is likely that a polarization switch occurs in Mφs from a M1 pro-
gram during the acute phase to the M2 programs through later
stages. Although there is no overwhelming evidence conﬁrming
the abundance of M2 Mφs in either the asymptotic or AIDS phase
in vivo, the fact CD163 (a M2 Mφ cell surface marker) is consid-
ered as a potential biomarker for HIV-1 disease progression may
allude to the presence of M2 Mφs in HIV-1-infected individuals
(Burdo et al., 2011; Tippett et al., 2011). Similar to M1 Mφs, it
is not known whether M2 Mφs beneﬁts the host during HIV-1
infection. In vitro activation of M2a (IL-4-treated) Mφs results in
inhibition of virus replication (Cassol et al., 2009). Other stud-
ies have demonstrated that both IL-4 and IL-13 down-regulate
viral entry receptors andHIV-1 reverse transcription inMφs (Cas-
sol et al., 2010). Furthermore, activation of M2c (IL-10-treated)
Mφs strongly inhibits reverse transcription, transcription of HIV-
1 LTR and viral assembly (Herbein and Varin, 2010). Based on
these observations, it might be tempting to conclude that M2 Mφs
are beneﬁcial to host immunity against HIV. However, the pro-
gression of AIDS is characterized by the loss of IL-2 and increase
of IL-10 correlating with HIV viremia (Brockman et al., 2009;
Sandanger et al., 2009). Moreover, the haplotypes of both IL-4
and IL-10 genes have been associated recently with AIDS progres-
sion (Vasilescu et al., 2003). Therefore, the switch toward a M2
Mφ program might simply be part of a defensive mechanism by
the host to control HIV-induced tissue damage since they par-
ticipate in suppression of inﬂammation and promotion of tissue
repair (Figure 1; Martinez et al., 2009; Murray and Wynn, 2011).
Recently, a functional proteomic analysis of HIV-infected Mφs in
the presence of regulatory T cells showed that a deviation of M1
to M2 Mφ program is associated with neuroprotection in the case
of HIV-associated neurocognitive disorders, suggesting M2 Mφs
may curtail the M1HIV polarized activity resulting in tissue dam-
age (Huang et al., 2010). Conversely, the switch toward the M2
Mφ program might also occur as an evasion strategy by HIV to
promote its own survival. A recent study demonstrated that HIV
up-regulates both programmed cell death ligand 1 (PD-L1) and
PD-L2 expression, members of the B7:CD28 family, and PD-1 lig-
ands, in Mφs (Porichis et al., 2011). Given the importance of these
molecules in T cell exhaustion during HIV infection, the ability
of IL-10 to both activate the M2c Mφ program and induce PD-
L1, and the fact that IL-10 production and increased expression
of PD-L1 correlate in HIV-infected patients, the authors propose
the manipulation of PDL expression in Mφs as a strategy to evade
immune responses (Trabattoni et al., 2003; Porichis et al., 2011).
Whatever the true role of M2 Mφs in HIV infection, it is clear they
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inﬂuence the establishment of HIV pathogenesis, and more stud-
ies are needed to examine thoroughly HIV-induced polarization
of Mφs in vivo.
CONCLUSION
Tuberculosis is the most common opportunistic infection inAIDS
and often used as a clinical parameter for undiagnosed AIDS
cases (Deretic et al., 2004). While the synergy between Mtb and
HIV is evident at the clinical level, the mechanisms account-
ing for it are poorly understood. Deretic et al. (2004) proposed
the interference with endosomal sorting machine as a molecu-
lar mechanism contributing to the synergy between these two
pathogens. Likewise, we envision the pathogenic modulation of
Mφ polarization as a cellular mechanism that might inﬂuence
this synergism. As aforementioned, it is estimated that about one-
third of the human population may be latently infected with Mtb
(WHO Global Tuberculosis Control Report 2010, 2010), suggest-
ing that one in three of the 2.6 million people newly infected
with HIV-1 in 2009 (Cohen et al., 2011), for example, would also
be coinfected with Mtb. Latent Mtb is conﬁned in solid gran-
ulomas composed of mainly by Mφs and T cells that maintain
their stability. The coinfection with HIV-1 results in a dramatic
increase in the odds of latently infected people progressing into
overt TB to a staggering annual risk of 10% (Deretic et al., 2004;
Swaminathan et al., 2010). HIV-driven immune perturbation,
reﬂected in the loss of CD4+ T cells and abnormal low levels
of TNFα causes the loss of granuloma integrity and efﬁciency in
anti-microbial containment leading to post-primary reactivation
state (Paige and Bishai, 2010). These events may increase both
Mφ necrosis and release of intracellular bacilli accounting for
the extrapulmonary TB manifestation diagnosed in patients with
HIV-driven immunosuppression (Swaminathan et al., 2010). The
awakened Mtb then might induce M1 Mφs to drive an excessive
TNFα response (together with other mechanisms such as MMP
secretion) to deliberately promote parasitic granuloma formation,
resulting in the recruitment of additional naïve Mφs and the tissue
pathology (Davis andRamakrishnan, 2009; Paige andBishai, 2010;
Volkman et al., 2010). Excessive levels of TNFα, may not only con-
tribute to the classical symptoms of cachexia in TB, but also to the
augmentation of HIV-1 transcription and accelerated formation
of viral reservoirs (Deretic et al., 2004). In the absence of an efﬁ-
cient adaptive immune response due to HIV-driven impairment,
uncontrolled inﬂammation can result in lung immunopathology,
and consequently, the host may induce tissue repair responses.
The shift from M1 to M2 Mφ program may become pronounced
and prolonged in the sterile attempt to restore tissue integrity,
elevating the level of IL-10 that is typical of disease progression
by both pathogens, and thus contributing to the failure of all
immunological functions and clinical collapse. While highly spec-
ulative, this scenario highlights the importance to understand Mφ
polarization in the context of immune activation and pathogen-
driven disease, and its potential to be yet another convergence
point targeted by Mtb and HIV to circumvent the host immune
system.
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